Akira Hayasaka - Research Division, Chugai Pharmaceutical Co., Ltd

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 18 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Beyond Recycling Antibodies: Crovalimab’s Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment

Zenjiro Sampei, Kenta Haraya, Siok Wan Gan,Masaru Muraoka,Akira Hayasaka, Taku Fukuzawa, Meiri Shida-Kawazoe, Yoshinori Tsuboi,Akihiko Gotoh,Naoshi Obara, Yasutaka Ueda

International Journal of Molecular Sciencesno. 21 (2024): 11679

Cited0Views0Bibtex

Characterizations of a Neutralizing Antibody Broadly Reactive to Multiple Gluten Peptide:Hla-Dq2.5 Complexes in the Context of Celiac Disease

Yuu Okura, Yuri Ikawa-Teranishi, Akihiko Mizoroki,Noriyuki Takahashi,Takashi Tsushima,Machiko Irie, Zulkarnain Harfuddin, Momoko Miura-Okuda,Shunsuke Ito,Genki Nakamura,Hiroaki Takesue,Yui Ozono,Masamichi Nishihara,Kenta Yamada,Siok Wan Gan,Akira Hayasaka,Shinya Ishii,Tetsuya Wakabayashi,Masaru Muraoka, Nishiki Nagaya,Hiroshi Hino,Takayuki Nemoto,Taichi Kuramochi,Takuya Torizawa,Hideaki Shimada,Takehisa Kitazawa,Makoto Okazaki,Junichi Nezu,Ludvig M. Sollid,Tomoyuki Igawa

Nature communicationsno. 1 (2023)

Cited0Views0WOSNATUREBibtex

Efficient Production of Bispecific Antibody by FAST-Ig TM and Its Application to NXT007 for the Treatment of Hemophilia A

Hikaru Koga,Takashi Yamano, Juan Betancur, Satoko Nagatomo, Yousuke Ikeda,Kazuki Yamaguchi,Yoshiaki Nabuchi,Kazuki Sato,Yuri Teranishi-Ikawa,Motohiko Sato, Hiroyuki Hirayama,Akira Hayasaka,Takuya Torizawa,Kenta Haraya,Zenjiro Sampei,Hirotake Shiraiwa,Takehisa Kitazawa,Tomoyuki Igawa,Taichi Kuramochi

MABS（2023）

Cited0Views0WOSBibtex

Validation of a Method to Analyze Size Distribution of Crovalimab-Complement C5-eculizumab Complexes in Human Serum

Masanobu Nishidate,Norihito Shibahara,Akira Hayasaka,Roland F. Staack,Takashi Miyayama,Kimio Terao,Gregor Jordan

Bioanalysis（2022）

Cited2Views0WOSBibtex

Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment

Futa Mimoto,Kanako Tatsumi,Shun Shimizu,Shojiro Kadono,Kenta Haraya,Miho Nagayasu, Yuki Suzuki,Etsuko Fujii,Masaki Kamimura,Akira Hayasaka,Hiroki Kawauchi,Kazuhiro Ohara,Masayuki Matsushita,Takeshi Baba, Hiroaki Susumu, Takuya Sakashita,Terushige Muraoka, Kosuke Aso,Hitoshi Katada,Eriko Tanaka, Kenji Nakagawa,Masami Hasegawa,Miho Ayabe,Tessai Yamamoto, Shigero Tanba,Takahiro Ishiguro,Takayuki Kamikawa,Takeru Nambu,Tatsuya Kibayashi,Yumiko Azuma, Yasushi Tomii,Atsuhiko Kato,Kazuhisa Ozeki,Naoaki Murao,Mika Endo,Junichi Kikuta,Mika Kamata-Sakurai,Masaru Ishii,Kunihiro Hattori,Tomoyuki Igawa

Cell reportsno. 12 (2020): 108542-108542

Cited39Views0WOSBibtex

Small-scale screening method for low-viscosity antibody solutions using small-angle X-ray scattering

Masakazu Fukuda, Atsushi Watanabe,Akira Hayasaka,Masaru Muraoka,Yuji Hori,Tadao Yamazaki,Yoshimi Imaeda,Akiko Koga

European Journal of Pharmaceutics and Biopharmaceutics（2017）

Cited19Views0WOSBibtex

The Optimal Duration of Pth(1-34) Infusion is One Hour Per Day to Increase Bone Mass in Rats

Masaru Shimizu,Hiroshi Noda,Eri Joyashiki, Chie Nakagawa,Kentaro Asanuma,Akira Hayasaka,Motohiro Kato,Masahiko Nanami,Masaki Inada,Chisato Miyaura,Tatsuya Tamura

Biological & pharmaceutical bulletin（2016）

Cited14Views0WOSBibtex

Formulation pharmaceutique contenant des molécules d'anticorps améliorées

Tomoyuki Igawa,Shinya Ishii,Atsuhiko Maeda,Mika Sakurai,Tetsuo Kojima,Tatsuhiko Tachibana,Hirotake Shiraiwa,Hiroyuki Tsunoda,Yoshinobu Higuchi,Chifumi Moriyama,Akira Hayasaka

mag（2010）

Cited23Views0Bibtex

Pharmaceutical formulation containing improved antibody molecules

Tomoyuki Igawa,Shinya Ishii,Atsuhiko Maeda,Mika Sakurai,Tetsuo Kojima,Tatsuhiko Tachibana,Hirotake Shiraiwa,Hiroyuki Tsunoda,Yoshinobu Higuchi,Chifumi Moriyama,Akira Hayasaka

mag（2010）

Cited26Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn